The Transatlantic Networks of Excellence Program grant recipients are listed below by year, project title and principal coordinators. For information about each network, please click below:

2012

1. Pathogenesis of Small vessel Disease of the Brain
   Anne JOUTEL, INSERM, Paris 7
   Mark T. NELSON, University of Vermont, Burlington
2. Understanding coronary artery disease genes
   A. Jake LUSIS, University of California; Los Angeles
   Heribert SCHUNKERT, University of Lübeck
3. MIBAVA-Mechanistic Interrogation of Bicuspid Aortic Valve associated Aortopathy
   Bart LOEYS, University of Antwerp
   Harry DIETZ, John Hopkins University, Baltimore
4. TNT-Triglyceride Metabolism in Obesity and Cardiovascular Disease
   Rudolf ZECHNER, University of Graz
   Stephen G. YOUNG, UCLA, Los Angeles

2011

1. Genomic, epigenomic and systems dissection of mechanisms underlying dilated cardiomyopathy
   Christine SEIDMAN, Harvard Medical School, Boston
   Stuart COOK, Imperial College Faculty of Medicine, London
2. Translating human pluripotent stem cells from heart disease models to cardiac repair
   Michel PUCEAT, Université Paris Descartes, INSERM U633, Evry
   Andre TERZIC, Mayo Clinic, Rochester
3. Lymph vessels in obesity and cardiovascular disease
   Kari ALITALO, University of Helsinki
   Mark KAHN, University of Pennsylvania, Philadelphia
4. Proteotoxicity:  an unappreciated mechanism of heart disease and its potential for novel therapeutics
   Jeffrey ROBBINS, Cincinnati Children's Hospital
   Mathias GAUTEL, King's College, London

2010

1. Transatlantic Network on newborn stroke:  inflammatory modulation of neurovascular injury
   Pierre GRESSENS, Hôpital Robert Debré, INSERM U676, Paris
   Donna FERRIERO, University of California, San Francisco
2. Multidisciplinary program to elucidate the role of bone morphogenetic protein signaling in the pathogenesis of pulmonary and systemic vascular diseases   Kenneth BLOCH, Harvard Medical School, Boston
   Nicholas MORRELL, University of Cambridge
3. Molecular mechanisms of novel genes associated with plasma lipids and cardiovascular disease
   Daniel RADER, University of Pennsylvania, Philadelphia
   Christian WEBER, RWTH Aachen University
4. High-density lipoprotein dysfunction in the development of cardiovascular disease and as a therapeutic target
   Thomas LUSCHER, University of Zurich
   Alan FOGELMAN, University of California, Los Angeles

2009

1. Redox and nitrosative regulation of cardiac remodeling:  novel therapeutic approaches for heart failure 
   Ajay SHAH, King's College, London
   David KASS, Johns Hopkins University, Baltimore
2. Leducq Transatlantic Network on therapeutic arteriogenesis and metabolism modulation
   Michael SIMONS, Yale University, New Haven
   Peter CARMELIET, Catholic University of Leuven
3. Structural alterations in the myocardium and the substrate for cardiac fibrillation 
   Jose JALIFE, University of Michigan, Ann Arbor
   Stéphane HATEM, Université Pierre Marie Curie, Paris
4. Multi-scale modeling of single ventricle hearts for clinical decision support
   Tain-Yen HSIA, Great Ormond Street Hospital for Children, London
   Richard FIGLIOLA, Clemson University

2008

1. Alliance for Calmodulin Kinase II Signaling in Heart Failure and Arrhythmias
   Mark E. ANDERSON, University of Iowa, Iowa City
   Silvia G. PRIORI, University of Pavia
2. Mechanisms matching the brain's vascular energy supply to neural activity, and their disruption after stroke
   Brian MacVICAR, University of British Columbia, Vancouver
   David ATTWELL, University College, London
3. MicroRNAs as therapeutic targets in heart failure
   Eric N. OLSON, University of Texas Southwestern Medical Center, Dallas
   Stefan ENGELHARDT, Technische Universität München

2007

1. Transatlantic Network on Hypertension – Renal Salt Handling in the Control of Blood Pressure
   Steven C. HEBERT (†15/04/2008)/Richard LIFTON, Yale University School of Medicine, New Haven
   Bernard C. ROSSIER, University of Lausanne
2. Transatlantic Network of Excellence for the Identification of Novel Genetic Targets in Hemorrhagic Stroke
   Elisabetta DEJANA, Institute for Molecular Oncology Foundation, Milan
   Brant WEINSTEIN, National Institutes of Health, Bethesda
3. European-North American Atrial Fibrillation Research Alliance (ENAFRA)
   Dobromir DOBREV, University of Heidelberg, Mannheim
   Stanley NATTEL, Montreal Heart Institute
4. Mitral Valve Disease: From Genetic Mechanisms to Improved Repair
   Robert A. LEVINE, Massachusetts General Hospital, Boston
   Albert A. HAGÈGE, Hôpital Européen Georges Pompidou, Paris

2006
2005
2004